Thu, November 2, 2023
Wed, November 1, 2023
Tue, October 31, 2023

Joseph Pantginis Reiterated (APRE) at Strong Buy and Held Target at $20 on, Nov 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-20-on-nov-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Pantginis of HC Wainwright & Co., Reiterated "Aprea Therapeutics, Inc." (APRE) at Strong Buy and Held Target at $20 on, Nov 1st, 2023.

Joseph, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources